Olivia Manser | executive |
Christian Itin | executive |
Robert Dolski | executive |
Gil Blum | analyst |
Asthika Goonewardene | analyst |
Dingding Shi | analyst |
James Shin | analyst |
Matthew Phipps | analyst |
Yanan Zhu | analyst |
Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics call to discuss its second quarter 2024 financial results and business updates.
As a reminder, this conference call is being recorded. I would now like to turn this conference over to your host, Olivia Manser.
Thanks, Sean. Good morning or good afternoon, everyone, and thanks for joining us on today's call.